Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India (Q46804304)

25 December 2017

title

Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India (English)

1 reference

25 December 2017

0 references

1 reference

1

1 reference

25 December 2017

author name string

Rath K

2

1 reference

25 December 2017

Kerketta AS

3

1 reference

25 December 2017

Swain BK

4

1 reference

25 December 2017

Mishra S

5

1 reference

25 December 2017

Kar SK

6

1 reference

25 December 2017

publication date

8 November 2005

1 reference

25 December 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

published in

1 reference

25 December 2017

volume

100

1 reference

25 December 2017

page(s)

464-469

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

Mass treatment to eliminate filariasis in Papua New Guinea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

Tolerance of diethylcarbamazine by microfilaraemic and amicrofilaraemic individuals in an endemic area of Bancroftian filariasis, Recife, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

The global programme to eliminate lymphatic filariasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

The role of albendazole in programmes to eliminate lymphatic filariasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

Comparison of high dose ivermectin and diethylcarbamazine for activity against bancroftian filariasis in Haiti.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

Wolbachia bacteria of filarial nematodes: a target for control?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.07.016

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSTMH.2005.07.016

1 reference

25 December 2017

PubMed ID

16288792

1 reference

25 December 2017